Stock INLB ITEM 9 LABS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Item 9 Labs Corp.

Equities

INLB

US46564C2035

Healthcare Facilities & Services

Market Closed - OTC Markets
Other stock markets
 09:30:02 2024-04-24 am EDT 		5-day change 1st Jan Change
0.0001 USD 0.00% Intraday chart for Item 9 Labs Corp. 0.00% -94.74%
2023 Item 9 Labs Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
2023 Douglas Bowden Resigned as Chairman of the Board of Directors of Item 9 Labs Corp, Effective July 18, 2023 CI

Valuation

Fiscal Period: September 2018 2019 2020 2021 2022
Capitalization 1 16.19 177.2 81.55 144.5 37.61
Enterprise Value (EV) 1 16.02 181.9 89.35 164 65.37
P/E ratio -103 x -17.5 x -7.53 x -11.5 x -1.2 x
Yield - - - - -
Capitalization / Revenue 11.6 x 35.9 x 10 x 6.59 x 1.73 x
EV / Revenue 11.4 x 36.9 x 11 x 7.48 x 3 x
EV / EBITDA -26.5 x -44.6 x -19.1 x -37.4 x -5.76 x
EV / FCF -18,043,705 x -25,207,697 x 44,338,309 x -47,263,205 x 7,733,690 x
FCF Yield -0% -0% 0% -0% 0%
Price to Book 47 x 23.8 x 10.5 x 1.75 x 0.62 x
Nbr of stocks (in thousands) 7,361 63,515 54,365 90,910 95,213
Reference price 2 2.200 2.790 1.500 1.590 0.3950
Announcement Date 6/27/19 1/14/20 1/12/21 1/13/22 1/13/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2017 2018 2019 2020 2021 2022
Net sales 1 0.2551 1.402 4.934 8.122 21.94 21.76
EBITDA 1 -0.3941 -0.604 -4.077 -4.688 -4.38 -11.35
EBIT 1 -0.4357 -0.6538 -4.382 -5.326 -5.601 -13.12
Operating Margin -170.79% -46.64% -88.82% -65.58% -25.53% -60.3%
Earnings before Tax (EBT) 1 -0.4357 -0.6212 -9.949 -12.39 -10.91 -31.17
Net income 1 -0.4357 -0.6887 -9.825 -12.27 -10.91 -31.14
Net margin -170.79% -49.13% -199.12% -151.12% -49.71% -143.14%
EPS 2 -0.0579 -0.0213 -0.1597 -0.1992 -0.1388 -0.3300
Free Cash Flow - -0.8878 -7.218 2.015 -3.47 8.452
FCF margin - -63.33% -146.28% 24.81% -15.82% 38.85%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 6/27/19 6/27/19 1/14/20 1/12/21 1/13/22 1/13/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales 1 6.693 6.094 6.186 6.638 4.931 4.001 5.004
EBITDA - - - - - - -
EBIT 1 -0.2473 -5.505 -2.135 -2.772 -3.848 -4.366 -1.585
Operating Margin -3.69% -90.34% -34.51% -41.76% -78.03% -109.1% -31.68%
Earnings before Tax (EBT) 1 -0.8339 -9.046 -3.345 -3.869 -5.473 -18.48 -3.244
Net income 1 -0.8339 -9.046 -3.345 -3.878 -5.47 -18.45 -3.258
Net margin -12.46% -148.45% -54.07% -58.42% -110.93% -461.06% -65.1%
EPS 2 -0.0100 -0.1100 -0.0400 -0.0400 -0.0600 -0.2000 -0.0300
Dividend per Share - - - - - - -
Announcement Date 8/16/21 1/13/22 2/14/22 5/16/22 8/15/22 1/13/23 2/14/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2017 2018 2019 2020 2021 2022
Net Debt 1 - - 4.73 7.8 19.5 27.8
Net Cash position 1 0.01 0.17 - - - -
Leverage (Debt/EBITDA) - - -1.16 x -1.664 x -4.446 x -2.446 x
Free Cash Flow - -0.89 -7.22 2.02 -3.47 8.45
ROE (net income / shareholders' equity) - -40.2% -201% -160% -23.2% -42.1%
ROA (Net income/ Total Assets) - -13.5% -28.1% -18.9% -5.09% -7.21%
Assets 1 - 5.111 35.01 64.78 214.1 432.1
Book Value Per Share 2 0.1300 0.0500 0.1200 0.1400 0.9100 0.6300
Cash Flow per Share 2 0 0.0300 0 0 0.0200 0
Capex - 0.34 6.01 0.17 2.24 4.33
Capex / Sales - 24.27% 121.74% 2.06% 10.22% 19.89%
Announcement Date 6/27/19 6/27/19 1/14/20 1/12/21 1/13/22 1/13/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Farming

1st Jan change Capi.
ITEM 9 LABS CORP. Stock Item 9 Labs Corp.
-94.74% 70.19K
ASCEND WELLNESS HOLDINGS, INC. Stock Ascend Wellness Holdings, Inc.
+31.96% 272M
AYR WELLNESS INC. Stock Ayr Wellness Inc.
+33.74% 261M
ORGANIGRAM HOLDINGS INC. Stock Organigram Holdings Inc.
+49.42% 194M
JUSHI HOLDINGS INC. Stock Jushi Holdings Inc.
+44.98% 131M
IANTHUS CAPITAL HOLDINGS, INC. Stock iAnthus Capital Holdings, Inc.
-28.57% 121M
INTERCURE LTD. Stock InterCure Ltd.
+115.91% 119M
THE CANNABIST COMPANY HOLDINGS INC. Stock The Cannabist Company Holdings Inc.
-42.17% 119M
4FRONT VENTURES CORP. Stock 4Front Ventures Corp.
0.00% 86.82M
BAKHU HOLDINGS, CORP. Stock Bakhu Holdings, Corp.
+150.00% 75.33M
Medical Farming
  1. Stock Market
  2. Equities
  3. INLB Stock
  4. Financials Item 9 Labs Corp.